USMLE Forum Archives - USMLE Step 3 - THORACIC CA 5
THORACIC CA 5
sudha2015 - 02-16-11 10:18
In the large, phase III trial, patients were randomized to second-line therapy for advanced NSCLC with either gefitinib or docetaxel. Patients with EGFR mutations that were randomized to gefitinib had superior _____ relative to patients that were randomized to receive docetaxel
1. All of the answers are correct
2. PFS
3. ORR
4. ORR and PFS
5. OS
sudha2015 - 02-16-11 10:18
In the large, phase III trial, patients were randomized to second-line therapy for advanced NSCLC with either gefitinib or docetaxel. Patients with EGFR mutations that were randomized to gefitinib had superior _____ relative to patients that were randomized to receive docetaxel
1. All of the answers are correct
2. PFS
3. ORR
4. ORR and PFS
5. OS
Page 1
Page 1